Dr. Zilin Huang 黄子林
Chief Physician
Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Image-guided minimally invasive interventional therapy for solid tumors, including liver, lung, and bone cancers. Techniques include radiofrequency, microwave, and argon-helium cryoablation. Also treats advanced liver cancer with vascular intervention combined with targeted and immunotherapy.
Dr. Huang graduated from Sun Yat-sen University of Medical Sciences in 1991. As a Chief Physician, Dr. Huang focuses on tumor imaging diagnosis and minimally invasive interventional therapy. Research interests include radiofrequency, microwave, and cryoablation, radioactive seed implantation, and vascular intervention.
Professional roles
- Member, Tumor Minimally Invasive Therapy Professional Committee, China Anti-Cancer Association
- Member, Liver Cancer Professional Committee, Guangdong Anti-Cancer Association
- Standing Committee Member, Tumor Minimally Invasive Therapy Professional Committee, Guangzhou Anti-Cancer Association
- Member, Asian Society of Cryosurgery
Name order: in Chinese the family name comes first (Huang Zilin). Papers usually list the name as Zilin Huang or Huang Z.
Selected publications
21 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2025 (senior author): PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy. PubMed 40574845
- Front Oncol, 2020 (senior author): Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma. PubMed 32587825
- J Cell Biochem, 2020 (senior author): Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma. PubMed 31642123
- World J Gastrointest Oncol, 2019 (first author): Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets. PubMed 31798779
- World J Gastroenterol, 2019 (senior author): Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma. PubMed 31558872
- Aging (Albany NY), 2019 (senior author): Alternative splicing events are prognostic in hepatocellular carcinoma. PubMed 31301224
- J Neurosurg Spine, 2012 (senior author): Retroperitoneal schwannoma treated with percutaneous computed tomography-guided radiofrequency ablation. PubMed 22657948
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion